CAR T-cell therapy stands as a topic of great interest and debate in multiple myeloma (MM), with many trials ongoing around the world. He Huang, MD, PhD, Zhejiang University School of Medicine, Zhejiang, China, presents an update on the CAR-T experience in China, discussing ongoing trials and developments in MM. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.